References
- von Noorden GK, Campos EC. Binocular vision and ccular motility, 6th ed. Missouori: CV Mosby, 2002;246-97
- Scott WE. Full-time occlusion therapy for amblyopia. Am Orthopt J 1980;30:125-30
- Daw NW. Critical periods and amblyopia. Arch Ophthalmol 1998;116:502-5
- Hubel DH, Wiesel TN. The period of susceptibility to the physiological effects of unilateral eye closure in kittens. J Physiol 1970;206:419-36
- Hussein MA, Coats DK, Muthialu A, et al. Risk factors for treatment failure of anisometropic amblyopia. J AAPOS 2004;8:429-34 https://doi.org/10.1016/j.jaapos.2003.09.005
- Flynn JT, Schiffman J, Feuer W, Corona A. The therapy of amblyopia: an analysis of the results of amblyopia therapy utilizing the pooled data of published studies. Trans Am Ophthalmol Soc 1998;96:431-50
- Rustein RP, Fuhr PS. Efficacy and stability of amblyopia therapy. Optom Vis Sci 1992;69:747-54 https://doi.org/10.1097/00006324-199210000-00001
- Ahn JK, Hwang JM. Efficacy of occlusion therapy in amblyopia patients older than 9 years of age. J Korean Ophthalmol Soc 2002;43:1724-9
- Moon CS, Jin YH. Timing of amlyopia therapy in pure anisometropic amblyopia. J Korean Ophthalmol Soc 1998;39:185-92
- Levartovsky S, Oliver M, Gottesman N, Shimshoni M. Factors affecting long term results of successfully treated amblyopia: initial visulal acuity and type of amblyopia. Br J Ophthalmol 1995;79:225-8 https://doi.org/10.1136/bjo.79.3.225
- Oliver M, Neumann R, Chaimovitch Y, et al. Compliance and results of treatment for amblyopia in children more than 8 years old. Am J Ophthalmol 1986;102:340-5
- Epelbaum M, Milleret C, Buisseret P, Dufier JL. The sensitive period of strabismic amblyopia in humans. Ophthalmology 1993;100:323-7
- Simons K, Stein L, Sener EC, et al. Full-time atropine, intermittent atropine, and optical penalization and binocular outcome in treatment of strabismic amblyopia. Ophthalmology 1997;104:2143-55
- Smith LK, Thompsin JR, Woodruff G, Hiscox F. Factors affecting treatment compliance in amblyopia. J Pediatr Ophthalmol Strabismus 1995;32:98-101
- Ku HC, Lee SY, Lee YC. Clinical features and counterplans of monocular amblyopia failed to occlusion therapy. J Korean Ophthalmol Soc 2005;46:1158-66
- Mintz-Hittner HA, Fernandez KM. Successful amblyopia therapy initiated after age 7 years: compliance cures. Arch Ophthalmol 2000;118:1535-41
- Cobb CJ, Russell K, Cox A, MacEwen CJ. Factors influencing visual outcome in anisometropic amblyopes. Br J Ophthalmol 2002;86:1278-81 https://doi.org/10.1136/bjo.86.11.1278
- Park YK, Yoon KC, Park YG. Clinical approach for the treatment of amblyopia in school children. J Korean Ophthalmol Soc 2003;44:2091-8
- Oh DE, Lim KH. Efficacy of occlusion therapy in Amblyopia: type, depth & timing of amblyopia. J Korean Ophthalmol Soc 2003;44:2850-6
- Rho SS, Yang HS, Chang YH, et al. The effect on outcome of amblyopia treatment in children with anisometropic amblyopia. J Korean Ophthalmol Soc 2007;48:535-40
- Kim YH, Choi MY. The prospective comparison of the efficacy of intermittent atropine penalization and part-time occlusion therapy. J Korean Ophthalmol Soc 2008;49:958-66 https://doi.org/10.3341/jkos.2008.49.6.958
- The Pediatric Eye Disease Investigator Group. A randomized trial of atropine vs patching for treatment of moderate amblyopia in children. Arch Ophthalmol 2002;120:268-78 https://doi.org/10.1001/archopht.120.3.268
- The Pediatric Eye Disease Investigator Group. A comparison of atropine and patching treatments for moderate amblyopia by patient age, cause of amblyopia, depth of amblyopia, and other factors. Ophthalmology 2003;110:1632-8 https://doi.org/10.1016/S0161-6420(03)00500-1
- The Pediatric Eye Disease Investigator Group. Two-year followup of a 6-month randomized trial of atropine vs patching for treatment of moderate amblyopia in children. Arch Ophthalmol 2005;123:149-57 https://doi.org/10.1001/archopht.123.2.149
- Yu DK, Choi MY. The efficacy of intermittent atropine penalization in amblyopic children who have failed patching therapy. J Korean Ophthalmol Soc 2005;46:1167-74
- Leiba H, Shimshoni M, Oliver M, et al. Long term follow-up of occlusion therapy in amblyopia. Ophthalmology 2001;108:1552-5 https://doi.org/10.1016/S0161-6420(01)00697-2
- Ohlsson J, Banumann M, Sjostrand J, Abrahamsson M. Long term visual outcome in amblyopic treatment. Br J Ophthalmol 2002;86:1148-51 https://doi.org/10.1136/bjo.86.10.1148
- Ching FC, Parks MM, Friendly DS, et al. Practical management of amblyopia. J Pediatr Ophthalmol Strabismus 1986;23:12-6
- Levartovsky S, Gottesman N, Shimshoni M, Oliver M. Factors affecting long-term results successfully treated amblyopia: age at beginning of treatment and age at cessation of monitoring. J Pediatr Ophthalmol Strabismus 1992;29:219-23
- Bhola R, Keech RV, Kutscheke P, et al. Recurrence of amblyopia after occlusion therapy. Ophthalmology 2006;113:2097-100 https://doi.org/10.1016/j.ophtha.2006.04.034
Cited by
- 유소년 약시환자의 생활환경 특성과 학교신체검사 안검진의 신뢰성 vol.14, pp.6, 2010, https://doi.org/10.5392/jkca.2014.14.06.262
- Clinical Analysis of Factors Affecting Successful Occlusion Treatment and Visual Recovery Time in Amblyopia vol.58, pp.11, 2017, https://doi.org/10.3341/jkos.2017.58.11.1254
- Clinical Perceptions and Practice Patterns for Amblyopia in Korea vol.61, pp.2, 2020, https://doi.org/10.3341/jkos.2020.61.2.190